UnitedHealth Group (UNH) Income Statement Flow — TTM through Q2 2026
Calculated from the four most recent reported quarters, ending (reported ).
UnitedHealth Group (UNH) Revenue by Product Segment — TTM through Q2 2026
Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported segments changed mid-year.
| Segment | Revenue (USD) | % of total |
|---|---|---|
| Unitedhealthcare | $344B | 76.5% |
| Optumrx | $55.9B | 12.4% |
| Optumhealth | $42.9B | 9.5% |
| Optuminsight | $6.92B | 1.5% |
| Total | $450B | 100% |
- Unitedhealthcare$344B
- Optumrx$55.9B
- Optumhealth$42.9B
- Optuminsight$6.92B
- Total$450B
Revenue Breakdown — TTM through Q2 2026
In TTM through Q2 2026, UnitedHealth Group (UNH) reports revenue across 4 reportable product segments; the largest segment was Unitedhealthcare at 76.5%, followed by Optumrx (12.4%) and Optumhealth (9.5%).
Frequently asked questions
Data & methodology
UnitedHealth Group (UNH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.96% TTM
- Dividend Profile2.13% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.